These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12036724)

  • 1. Bioavailability and in vitro oesophageal sticking tendency of hydroxypropyl methylcellulose capsule formulations and corresponding gelatine capsule formulations.
    Honkanen O; Laaksonen P; Marvola J; Eerikäinen S; Tuominen R; Marvola M
    Eur J Pharm Sci; 2002 Jun; 15(5):479-88. PubMed ID: 12036724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma scintigraphic evaluation of the fate of hydroxypropyl methylcellulose capsules in the human gastrointestinal tract.
    Honkanen O; Marvola J; Kanerva H; Lindevall K; Lipponen M; Kekki T; Ahonen A; Marvola M
    Eur J Pharm Sci; 2004 Apr; 21(5):671-8. PubMed ID: 15066668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The shell dissolution of various empty hard capsules.
    Chiwele I; Jones BE; Podczeck F
    Chem Pharm Bull (Tokyo); 2000 Jul; 48(7):951-6. PubMed ID: 10923822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vitro dissolution of theophylline from different types of hard shell capsules.
    Podczeck F; Jones BE
    Drug Dev Ind Pharm; 2002 Oct; 28(9):1163-9. PubMed ID: 12455475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo pharmacoscintigraphic evaluation of ibuprofen hypromellose and gelatin capsules.
    Cole ET; Scott RA; Cade D; Connor AL; Wilding IR
    Pharm Res; 2004 May; 21(5):793-8. PubMed ID: 15180336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules.
    Sherry Ku M; Li W; Dulin W; Donahue F; Cade D; Benameur H; Hutchison K
    Int J Pharm; 2010 Feb; 386(1-2):30-41. PubMed ID: 19900518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of food on a gastrically degraded drug: azithromycin fast-dissolving gelatin capsules and HPMC capsules.
    Curatolo W; Liu P; Johnson BA; Hausberger A; Quan E; Vendola T; Vatsaraj N; Foulds G; Vincent J; Chandra R
    Pharm Res; 2011 Jul; 28(7):1531-9. PubMed ID: 21331473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of fill weight, capsule shell, and sinker design on the dissolution behavior of capsule formulations of a weak acid drug candidate BMS-309403.
    Wu Y; Zhao F; Paborji M
    Pharm Dev Technol; 2003; 8(4):379-83. PubMed ID: 14601962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPMC capsules: current status and future prospects.
    Al-Tabakha MM
    J Pharm Pharm Sci; 2010; 13(3):428-42. PubMed ID: 21092714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of particle size, food, and capsule shell composition on the oral bioavailability of dabrafenib, a BRAF inhibitor, in patients with BRAF mutation-positive tumors.
    Ouellet D; Grossmann KF; Limentani G; Nebot N; Lan K; Knowles L; Gordon MS; Sharma S; Infante JR; Lorusso PM; Pande G; Krachey EC; Blackman SC; Carson SW
    J Pharm Sci; 2013 Sep; 102(9):3100-9. PubMed ID: 23608920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The disintegration behaviour of capsules in fed subjects: a comparison of hypromellose (carrageenan) capsules and standard gelatin capsules.
    Jones BE; Basit AW; Tuleu C
    Int J Pharm; 2012 Mar; 424(1-2):40-3. PubMed ID: 22214655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the human in vivo performance of different oral capsule shell types using a novel in vitro dynamic gastric model.
    Vardakou M; Mercuri A; Naylor TA; Rizzo D; Butler JM; Connolly PC; Wickham MS; Faulks RM
    Int J Pharm; 2011 Oct; 419(1-2):192-9. PubMed ID: 21843611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of capsule type on aerodynamic performance of inhalation products: A case study using a formoterol-lactose binary or ternary blend.
    Wauthoz N; Hennia I; Ecenarro S; Amighi K
    Int J Pharm; 2018 Dec; 553(1-2):47-56. PubMed ID: 30321640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of active pharmaceutical material release from a novel 'tablet in capsule system' containing an effervescent blend.
    Gohel MC; Sumitra G M
    J Control Release; 2002 Feb; 79(1-3):157-64. PubMed ID: 11853927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A scintigraphic investigation of the disintegration behaviour of capsules in fasting subjects: a comparison of hypromellose capsules containing carrageenan as a gelling agent and standard gelatin capsules.
    Tuleu C; Khela MK; Evans DF; Jones BE; Nagata S; Basit AW
    Eur J Pharm Sci; 2007 Mar; 30(3-4):251-5. PubMed ID: 17188473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time domain 1H NMR as a new method to monitor softening of gelatin and HPMC capsule shells.
    Kuentz M; Rothenhäusler B; Röthlisberger D
    Drug Dev Ind Pharm; 2006; 32(10):1165-73. PubMed ID: 17090439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of ibuprofen from hot-melt extruded mini-matrices.
    De Brabander C; Vervaet C; Van Bortel L; Remon JP
    Int J Pharm; 2004 Mar; 271(1-2):77-84. PubMed ID: 15129975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of hydroxypropyl methylcellulose mixture, apparent viscosity, and tablet hardness on drug release using a 2(3) full factorial design.
    Khanvilkar KH; Huang Y; Moore AD
    Drug Dev Ind Pharm; 2002 May; 28(5):601-8. PubMed ID: 12098849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged-release hard gelatin capsules of furosemide for the treatment of dogs.
    Smal J; Haapala O; Marvola M; Kuusela S; Happonen I
    J Vet Pharmacol Ther; 1995 Feb; 18(1):17-23. PubMed ID: 7752301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan-Hydroxypropyl Methylcellulose Matrices as Carriers for Hydrodynamically Balanced Capsules of Moxifloxacin HCl.
    Verma A; Dubey J; Verma N; Nayak AK
    Curr Drug Deliv; 2017; 14(1):83-90. PubMed ID: 27142106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.